These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 22054870)

  • 1. A genome-wide scan for common variants affecting the rate of age-related cognitive decline.
    De Jager PL; Shulman JM; Chibnik LB; Keenan BT; Raj T; Wilson RS; Yu L; Leurgans SE; Tran D; Aubin C; Anderson CD; Biffi A; Corneveaux JJ; Huentelman MJ; ; Rosand J; Daly MJ; Myers AJ; Reiman EM; Bennett DA; Evans DA
    Neurobiol Aging; 2012 May; 33(5):1017.e1-15. PubMed ID: 22054870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polygenic analysis of inflammatory disease variants and effects on microglia in the aging brain.
    Felsky D; Patrick E; Schneider JA; Mostafavi S; Gaiteri C; Patsopoulos N; Bennett DA; De Jager PL
    Mol Neurodegener; 2018 Jul; 13(1):38. PubMed ID: 30041668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional data.
    White CC; Yang HS; Yu L; Chibnik LB; Dawe RJ; Yang J; Klein HU; Felsky D; Ramos-Miguel A; Arfanakis K; Honer WG; Sperling RA; Schneider JA; Bennett DA; De Jager PL
    PLoS Med; 2017 Apr; 14(4):e1002287. PubMed ID: 28441426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A TREM1 variant alters the accumulation of Alzheimer-related amyloid pathology.
    Replogle JM; Chan G; White CC; Raj T; Winn PA; Evans DA; Sperling RA; Chibnik LB; Bradshaw EM; Schneider JA; Bennett DA; De Jager PL
    Ann Neurol; 2015 Mar; 77(3):469-77. PubMed ID: 25545807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.
    Sherva R; Tripodis Y; Bennett DA; Chibnik LB; Crane PK; de Jager PL; Farrer LA; Saykin AJ; Shulman JM; Naj A; Green RC; ; ;
    Alzheimers Dement; 2014 Jan; 10(1):45-52. PubMed ID: 23535033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic susceptibility for Alzheimer disease neuritic plaque pathology.
    Shulman JM; Chen K; Keenan BT; Chibnik LB; Fleisher A; Thiyyagura P; Roontiva A; McCabe C; Patsopoulos NA; Corneveaux JJ; Yu L; Huentelman MJ; Evans DA; Schneider JA; Reiman EM; De Jager PL; Bennett DA
    JAMA Neurol; 2013 Sep; 70(9):1150-7. PubMed ID: 23836404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort.
    Shen L; Kim S; Risacher SL; Nho K; Swaminathan S; West JD; Foroud T; Pankratz N; Moore JH; Sloan CD; Huentelman MJ; Craig DW; Dechairo BM; Potkin SG; Jack CR; Weiner MW; Saykin AJ;
    Neuroimage; 2010 Nov; 53(3):1051-63. PubMed ID: 20100581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation and neuroimaging measures in Alzheimer disease.
    Biffi A; Anderson CD; Desikan RS; Sabuncu M; Cortellini L; Schmansky N; Salat D; Rosand J;
    Arch Neurol; 2010 Jun; 67(6):677-85. PubMed ID: 20558387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genome-wide association study implicates the APOE locus in nonpathological cognitive ageing.
    Davies G; Harris SE; Reynolds CA; Payton A; Knight HM; Liewald DC; Lopez LM; Luciano M; Gow AJ; Corley J; Henderson R; Murray C; Pattie A; Fox HC; Redmond P; Lutz MW; Chiba-Falek O; Linnertz C; Saith S; Haggarty P; McNeill G; Ke X; Ollier W; Horan M; Roses AD; Ponting CP; Porteous DJ; Tenesa A; Pickles A; Starr JM; Whalley LJ; Pedersen NL; Pendleton N; Visscher PM; Deary IJ
    Mol Psychiatry; 2014 Jan; 19(1):76-87. PubMed ID: 23207651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study.
    Chuang YF; Varma V; An Y; Tanaka T; Davatzikos C; Resnick SM; Thambisetty M
    J Alzheimers Dis; 2020; 75(2):417-427. PubMed ID: 32250307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.
    Deming Y; Li Z; Kapoor M; Harari O; Del-Aguila JL; Black K; Carrell D; Cai Y; Fernandez MV; Budde J; Ma S; Saef B; Howells B; Huang KL; Bertelsen S; Fagan AM; Holtzman DM; Morris JC; Kim S; Saykin AJ; De Jager PL; Albert M; Moghekar A; O'Brien R; Riemenschneider M; Petersen RC; Blennow K; Zetterberg H; Minthon L; Van Deerlin VM; Lee VM; Shaw LM; Trojanowski JQ; Schellenberg G; Haines JL; Mayeux R; Pericak-Vance MA; Farrer LA; Peskind ER; Li G; Di Narzo AF; ; ; Kauwe JS; Goate AM; Cruchaga C
    Acta Neuropathol; 2017 May; 133(5):839-856. PubMed ID: 28247064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.
    Bunce D; Fratiglioni L; Small BJ; Winblad B; Bäckman L
    Neurology; 2004 Sep; 63(5):816-21. PubMed ID: 15365129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polygenic risk for Alzheimer's disease is not associated with cognitive ability or cognitive aging in non-demented older people.
    Harris SE; Davies G; Luciano M; Payton A; Fox HC; Haggarty P; Ollier W; Horan M; Porteous DJ; Starr JM; Whalley LJ; Pendleton N; Deary IJ
    J Alzheimers Dis; 2014; 39(3):565-74. PubMed ID: 24246418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Genetic Traits for Immune-Mediated Diseases and Alzheimer Disease.
    Yokoyama JS; Wang Y; Schork AJ; Thompson WK; Karch CM; Cruchaga C; McEvoy LK; Witoelar A; Chen CH; Holland D; Brewer JB; Franke A; Dillon WP; Wilson DM; Mukherjee P; Hess CP; Miller Z; Bonham LW; Shen J; Rabinovici GD; Rosen HJ; Miller BL; Hyman BT; Schellenberg GD; Karlsen TH; Andreassen OA; Dale AM; Desikan RS;
    JAMA Neurol; 2016 Jun; 73(6):691-7. PubMed ID: 27088644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermediate phenotypes identify divergent pathways to Alzheimer's disease.
    Shulman JM; Chibnik LB; Aubin C; Schneider JA; Bennett DA; De Jager PL
    PLoS One; 2010 Jun; 5(6):e11244. PubMed ID: 20574532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease genes and cognition in the nondemented general population.
    Verhaaren BF; Vernooij MW; Koudstaal PJ; Uitterlinden AG; van Duijn CM; Hofman A; Breteler MM; Ikram MA
    Biol Psychiatry; 2013 Mar; 73(5):429-34. PubMed ID: 22592056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
    Hsiung GY; Sadovnick AD; Feldman H
    CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E genotype and lifetime cognitive decline.
    Kozauer NA; Mielke MM; Chan GK; Rebok GW; Lyketsos CG
    Int Psychogeriatr; 2008 Feb; 20(1):109-23. PubMed ID: 17711604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.
    Han MR; Schellenberg GD; Wang LS;
    BMC Neurol; 2010 Oct; 10():90. PubMed ID: 20932310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.